Skip to main content
. 2018 Aug 26;2018:7624857. doi: 10.1155/2018/7624857

Table 3.

Antibiotic susceptibility of biofilm producer and non-biofilm producers.

Antibiotics Biofilm producer isolates (n=26) % Biofilm nonproducer isolates (n=33) % Resistance of all isolates (n=59) %
Gram-negatives isolates
Ampicillin 24 92.30 28 84.84 52 88.13
Ceftazolin 20 76.92 25 75.75 45 76.27
Gentamicin 14 53.84 11 30.30 25 42.37
Ciprofloxacin 19 73.07 23 69.69 42 71.18
Nitrofurantion 12 46.15 5 15.15 17 28.81
Amikacin 12 46.15 11 33.33 23 38.98
Amoxicillin-clavulanate 25 96.15 24 72.72 49 83.05
Piperacillin-tazobactam 7 26.92 7 21.22 14 23.72
Cefuroxime 20 76.92 24 72.72 44 74.57
Imipenem 5 19.23 1 3.03 6 10.16
Fosfomycin 3 11.5 1 3.03 4 6.77
Meropenem 14 53.84 12 36.36 26 44.06
Tetracyclin 19 73.07 17 51.51 36 61.01
Cotrimoxazol 17 65.38 21 63.63 38 64.40
Ceftazidime 21 80.76 21 63.63 42 71.18

Antibiotics Biofilm producer isolates (n=3) % Biofilm nonproducer isolates (n=3) % Resistance of all isolates (n=6) %

Gram-positive isolates
Ampicillin 2 66.67 1 33.33 3 50
Gentamicin 1 33.33 0 0.00 1 16.67
Ciprofloxacin 1 33.33 0 0.00 1 16.67
Nitrofurantion 1 33.33 0 0.00 1 16.67
Amoxicillin-clavulanate 3 100 1 33.33 4 66.67
Piperacillin-tazobactam 0 0.00 0 0.00 0 0.00
Meropenem 0 0.00 0 0.00 0 0.00
Tetracyclin 3 100 2 66.67 5 83.33
Cloxacillin 3 100 2 66.67 5 83.33
Vancomycin 0 0.00 0 0.00 0 0.00
Fosfomycin 0 0.00 0 0.00 0 0.00